Masatsugu Ueda
Comptroller/Controller/Auditor chez PHOENIXBIO CO., LTD.
Profil
Masatsugu Ueda is currently working as an Auditor at PhoenixBio Co., Ltd.
He previously worked as a Managing Director at Institute of Immunology Co., Ltd.
and as an MD & Manager-Transgenic Animal Division at PhoenixBio Co., Ltd.
Postes actifs de Masatsugu Ueda
| Sociétés | Poste | Début |
|---|---|---|
| PHOENIXBIO CO., LTD. | Comptroller/Controller/Auditor | 01/06/2019 |
Anciens postes connus de Masatsugu Ueda
| Sociétés | Poste | Fin |
|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
| PHOENIXBIO CO., LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHOENIXBIO CO., LTD. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
